[European Commission](https://commission.europa.eu/index_en)

February 2025 (Stage 1) | September 2025 (Stage 2)

Up to €8 million per project; typical project duration: 3–5 years.

Supports research and innovation to advance prevention, diagnosis, and treatment of major mental, behavioural, and neurodevelopmental disorders.

Two-stage application; open to international consortia.

--- ## Description This funding opportunity, offered under the Horizon Europe programme by the European Commission, aims to support ambitious research and innovation projects targeting improved understanding, prevention, diagnosis, and treatment of major mental, behavioural, and neurodevelopmental disorders. Projects are expected to deliver scientific excellence and drive the development of innovative solutions addressing key health challenges in Europe and globally. --- ## Due Dates - Stage 1 deadline (anticipated): February 2025 - Stage 2 deadline (anticipated): September 2025 *All dates are projected based on the annual cycle; check the program page for updates.* --- ## Funding Amount - Maximum funding per project: up to €8 million - Typical project duration: 3–5 years - Funding covers eligible direct and indirect costs --- ## Eligibility - Open to consortia including universities, research organizations, public and private entities, and SMEs from EU Member States and Horizon Europe Associated Countries. - Consortia must include at least three independent legal entities from three different eligible countries. - International partners outside the EU may participate under certain conditions. --- ## Application Process - Two-stage submission: an initial short proposal (Stage 1), followed by a full proposal (Stage 2) if invited. - Proposals must be submitted via the [EU Funding & Tenders Portal](https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-HLTH-2025-03-DISEASE-02-two-stage?isExactMatch=true&status=31094501,31094502&order=DESC&pageNumber=5&pageSize=50&sortBy=startDate). - Detailed guidance and requirements are provided in the official call documents on the portal. - Proposals are evaluated on excellence, impact, and quality of implementation. --- ## Additional Information - Projects should emphasize scientific excellence, societal impact, and potential for innovation. - Collaboration across disciplines and sectors is encouraged. - Open science practices and data sharing are expected. --- ## External Links - [EU Funding & Tenders Portal – Call Details](https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/opportunities/topic-details/HORIZON-HLTH-2025-03-DISEASE-02-two-stage?isExactMatch=true&status=31094501,31094502&order=DESC&pageNumber=5&pageSize=50&sortBy=startDate) - [European Commission – Horizon Europe](https://commission.europa.eu/research-and-innovation/funding/funding-opportunities/funding-programmes-and-open-calls/horizon-europe_en) --- ## Contact Information | Contact Type | Details | |------------------|------------------------------------------------------------------------------------------| | General Inquiries| [Contact the European Commission](https://commission.europa.eu/about-european-commission/contact_en) | | Phone | +32 2 299 11 11 | | Online Support | [Helpdesk & Support](https://ec.europa.eu/info/funding-tenders/opportunities/portal/screen/support/helpdesks) |

Advancing innovative interventions for mental, behavioural and neurodevelopmental disorders

Sign in to see full grant listing